Effect of hyperthermia on cisplatin sensitivity in human glioma and ovarian carcinoma cell lines resistant and sensitive to cisplatin treatment.
Two pairs of human tumour-cell lines consisting of a cisplatin sensitive and resistant line from glioma and ovarian carcinoma were tested to determine the effect of hyperthermia on cisplatin sensitization. Both cisplatin resistant lines were more sensitive to 42 degrees C heating than their cisplatin sensitive counterparts. The cisplatin response was dependent on cell growth phase, with plateau phase cells more sensitive than exponentially growing cells. The difference in cisplatin response between resistant and sensitive lines was also growth phase dependent and was opposite for the two cell line pairs. Hyperthermia caused about the same thermal sensitization in the plateau phase cisplatin sensitive cell lines and in the resistant lines but this too was growth-phase dependent. In exponentially growing cells hyperthermia-cisplatin sensitization was greater in the sensitive cell lines. Hyperthermia at 42 degrees C did not completely overcome cisplatin resistance but could be useful as a sensitizer in cisplatin resistant tumour cells.
Raaphorst
G P
GP
Ottawa Regional Cancer Centre, Ontario, Canada.
Chabot
P
P
Doja
S
S
Wilkins
D
D
Stewart
D
D
Ng
C E
CE
D000970:Antineoplastic Agents / Q000378:metabolism* / Q000627:therapeutic use; D002453:Cell Cycle / Q000502:physiology; D002455:Cell Division / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D002945:Cisplatin / Q000378:metabolism* / Q000627:therapeutic use; D002999:Clone Cells; D003131:Combined Modality Therapy; D019008:Drug Resistance, Neoplasm; D005260:Female; D005910:Glioma / Q000378:metabolism* / Q000473:pathology / Q000628:therapy; D006801:Humans; D006979:Hyperthermia, Induced; D010051:Ovarian Neoplasms / Q000378:metabolism* / Q000473:pathology / Q000628:therapy; D013696:Temperature; D014407:Tumor Cells, Cultured
D000970:Antineoplastic Agents; D002945:Cisplatin